Literature DB >> 27182527

Cardiac resynchronisation therapy after percutaneous mitral annuloplasty.

Janice Swampillai1.   

Abstract

Percutaneous approaches to reduce mitral regurgitation in ischemic cardiomyopathy have stirred interest recently. Patients with ischemic cardiomyopathy and functional mitral regurgitation often meet criteria for cardiac resynchronisation therapy to improve left ventricular function as well as mitral regurgitation, and alleviate symptoms. This case shows that implantation of a pacing lead in the coronary sinus to restore synchronous left and right ventricular contraction is feasible, despite the presence of a remodeling device in the coronary sinus.

Entities:  

Keywords:  Cardiac implantable electronic device; Cardiac resynchronisation therapy; Ischemic cardiomyopathy; Mitral regurgitation; Percutaneous mitral regurgitation

Year:  2016        PMID: 27182527      PMCID: PMC4857008          DOI: 10.12998/wjcc.v4.i5.127

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  4 in total

1.  Treatment of functional mitral valve regurgitation with the permanent percutaneous transvenous mitral annuloplasty system: results of the multicenter international Percutaneous Transvenous Mitral Annuloplasty System to Reduce Mitral Valve Regurgitation in Patients with Heart Failure trial.

Authors:  Jimmy Machaalany; Luc Bilodeau; Rainer Hoffmann; Stefan Sack; Horst Sievert; Josef Kautzner; Christoph Hehrlein; Patrick Serruys; Mario Sénéchal; Pamela Douglas; Olivier F Bertrand
Journal:  Am Heart J       Date:  2013-02-14       Impact factor: 4.749

2.  Transcatheter implantation of the MONARC coronary sinus device for mitral regurgitation: 1-year results from the EVOLUTION phase I study (Clinical Evaluation of the Edwards Lifesciences Percutaneous Mitral Annuloplasty System for the Treatment of Mitral Regurgitation).

Authors:  Jan Harnek; John G Webb; Karl-Heinz Kuck; Carsten Tschope; Alec Vahanian; Christopher E Buller; Stefan K James; Christiane P Tiefenbacher; Gregg W Stone
Journal:  JACC Cardiovasc Interv       Date:  2011-01       Impact factor: 11.195

3.  Percutaneous transvenous mitral annuloplasty: initial human experience with device implantation in the coronary sinus.

Authors:  John G Webb; Jan Harnek; Brad I Munt; Per Ola Kimblad; Mann Chandavimol; Christopher R Thompson; John R Mayo; Jan O Solem
Journal:  Circulation       Date:  2006-02-06       Impact factor: 29.690

Review 4.  Transcatheter mitral valve repair for functional mitral regurgitation: coronary sinus approach.

Authors:  Nicolo Piazza; Raoul Bonan
Journal:  J Interv Cardiol       Date:  2007-12       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.